期刊文献+

158例涂阴培阳肺结核患者分离菌株耐药情况分析 被引量:6

Drug resistance analysis of 158 isolated strains from patients with smear-negative and culture-positive tuberculosis
下载PDF
导出
摘要 目的了解湖北省涂阴培阳肺结核患者分离菌株耐药水平,为有效控制耐药结核病提供依据。方法采用WHO推荐的比例法,对湖北省内的4个国家级耐药监测点2013年获得的158例涂阴培阳患者的临床分离株进行药物敏感性试验(简称“药敏试验”),其中一线抗结核药物有异烟肼(H)、利福平(R)、链霉素(S)、乙胺丁醇(E)4种;二线抗结核药物有卡那霉素(Km)、卷曲霉素(Cm)、氧氟沙星(Ofx)、对氨基水杨酸(PAS)、丙硫异烟胺(Pto)5种。采用Excel建立数据库,采用SPSS16.0统计学软件进行分析,对耐药率的比较采用卡方检验,P〈0.05为差异有统计学意义。结果分离的158株菌株总体耐药率为18.99%(30/158),耐多药率为1.90%(3/158),一线药物S的耐药率最高为13.29%(21/158),二线药物Cm的耐药率最高为3.80%(6/158)。9种药物耐药率由高到低的顺位分别为S13.29%(21/158)、H9.49%(15/158)、Cm3.80%(6/158)、R3.16%(5/158)、PAS2.53%(4/158)、Km1.90%(3/158)、E1.27%(2/158)、Ofx1.27%(2/158)、Pto0.63%(1/158)。9种药物均出现了耐药菌株,共出现了15种不同耐药形式。4种一线药物耐药率为15.82%,与湖北省1999年耐药监测4种一线药物初始耐药率17.5%比较基本持平,差异无统计学意义(X^2=0.25,P〉0.05)。结论涂阴培阳肺结核患者分离株有较高的耐药率,应引起重视,加强监测,进行规范治疗和管理。 Objective To understand the drug-resistant level of strains isolated from patients with smear-ne- gative and culture-positive tuberculosis (TB) in Hubei, and to provide basis for effectively control drug-resistam TB. Methods Proportion method recommended by World Health Organization (WHO) was applied. Drug susceptibility test (DST) of H, R, S, E (the first-line anti-TB drugs) and Kin, Cm, Ofx, PAS, Pto (the second-line anti-TB drugs) for 158 isolated strains from patients with smear-negative and culture-positive TB from 4 national drug-re- sistance monitoring sites in Huhei in 2013 was conducted. Database was established using Excel. Statistical analysis was performed with SPSS 16.0. Chi-square test was used to test drug-resistance rate with P〈0.05 as statistically significant difference. Results The overall drug-resistance rate of 158 strains was 18. 99% (30/158), and the multi-drug resistant rate was 1.90% (3/158). Specifically, the drug-resistance rates of S and Cm were 13.29% (21/158) and 3.80% (6/158), which were respectively the highest among the first line and the second line drugs. Moreover,the drug-resistance rates of 9 drugs from high to low were S 13.29% (21/158), H 9.49% (15/158), Cm 3.80% (6/158), R 3.16% (5/158), PAS 2.53% (4/158), Km 1.90% (3/158), E 1.27% (2/158), Ofx 1.27% (2/158) and Pto 0.63% (1/158). Drug-resistant strains appeared to 9 drugs, and there were a total of 15 different forms of resistance. All in all, the drug-resistance rate of 4 kinds of first-line drugs was 15.82%, which kept basi- cally balance with the monitoring data 17.5% in Hubei in 1999 (X^2 =0. 25, P〉0.05). Conclusion The drug resistance rates of the isolated strains from patients with smear-negative and culture-positive TB are higher, which should be paid attention to, we should strengthen surveillance, and standardize treatment and management as well.
出处 《中国防痨杂志》 CAS 2015年第6期628-631,共4页 Chinese Journal of Antituberculosis
关键词 结核 抗药性 细菌 微生物敏感性试验 Tuberculosis, pulmonary Drug resistance, bacterial Microbial sensitivity tests
  • 相关文献

参考文献14

  • 1王黎霞,成诗明,陈明亭,赵雁林,张慧,姜世闻,何广学,吕青,杜昕,陈伟,刘小秋,阮云洲,王胜芬,夏愔愔,于兰,李峻,李雪,王宇,无.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012,34(8):485-508. 被引量:2428
  • 2中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育文化出版社,2006:33-37;49-51.
  • 3Mohamed AA, Adalbert L, Mario R, et al. Guidelines for sur- veillance of drug resistance in tuberculosis. 2nd ed. Geneva: World Health Organization, 2003 : 1-71.
  • 4World Health Organization. Guidelines {or drug susceptibility testing for second-line anti tuberculosis drugs for dots-plus. WHO/CDS/TB/2001. 288. Geneva: World Health Organiza- tion, 2001.
  • 5World Health Organization. Policy guidance on. drug-suscepti- bility testing (DST)of second-line anti tuberculosis drugs. WHO/HTM/TB/2008. 392. Geneva: World Health Organiza- tion, 2008.
  • 6赵雁林,姜广路,夏辉,等.痰涂片镜检标准化操作及质量保证手册.北京:中国协和医科大学出版社,2008:18-39.
  • 7赵雁林,王黎霞,成诗明,等.分枝杆菌病分离培养标准化操作及质量保证手册.北京:人民卫生出版社,2013:37-49.
  • 8郑蓉蓉,张向东,黄成基.875株结核分枝杆菌耐药情况分析[J].现代预防医学,2008,35(23):4697-4698. 被引量:5
  • 9李国明,吴兴荣,张缇,周丽平,李克国,刘勋,李爱国,戴宪法,袁方玉.湖北省结核分支杆菌耐药性监测研究[J].中华结核和呼吸杂志,2002,25(12):723-726. 被引量:39
  • 10中华人民共和国卫生部.全国结核病耐药性基线调查报(2007-2008年).北京:人民卫生出版社,2010:1-57.

二级参考文献78

共引文献2583

同被引文献27

引证文献6

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部